Navigation Links
Federal Court Asked to Compel Decision in Marijuana Scheduling Action
Date:5/24/2011

WASHINGTON, May 24, 2011 /PRNewswire-USNewswire/ -- A coalition of advocacy groups and patients yesterday filed suit in the U.S. Court of Appeals for the District of Columbia Circuit to compel the Obama Administration to formally respond to a 9-year-old petition to have marijuana rescheduled under the provisions of the Controlled Substances Act (CSA).

Relief sought from the Court of Appeals would enable states with medical marijuana laws to expedite efforts to change marijuana's status under federal law and narrow the widening gap between state and federal law.  For example, Washington Governor Chris Gregoire has expressed interest in having all the states that allow medical marijuana to ask the federal government to reclassify the drug.  If the Court of Appeals grants the relief requested by the CRC, Washington and other medical marijuana states would have the opportunity to seek rescheduling now in expedited proceedings, rather than wait years for a new rescheduling action to ripen.

The Coalition for Rescheduling Cannabis (CRC) argues that marijuana no longer satisfies the requirements of a Schedule I prohibited substance and that federal law requires that it be reclassified.  President Obama's Administration has had ample time to review the Coalition's administrative petition but has refused to take final action, violating the requirements of the Administrative Procedures Act which requires action within a reasonable period of time.

One of the requirements for maintaining a drug in Schedule I of the CSA is that it must not have accepted medical use in the United States.  Marijuana's medical use is now accepted by 16 states (Alaska, Arizona, California, Colorado, Delaware, Hawaii, Maine, Michigan, Montana, Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Vermont and Washington) as well as the District of Columbia.

According to Jon Gettman, coordinator of the CRC, "Marijuana has accepted medical use in the United States, it has a lower abuse potential than drugs like heroin, methamphetamine, and cocaine, and it is safe for use under medical supervision.  All of these characteristics are well-documented scientifically and legally.  Federal law requires the Obama Administration to reclassify marijuana."

"The federal government's strategy has been delay, delay, delay," said Joe Elford, Chief Counsel of ASA and lead counsel on the writ. "It is far past time for the government to answer our rescheduling petition, but unfortunately we've been forced to go to court in order to get resolution." The writ of mandamus filed accuses the government of unreasonable delay in violation of the Administrative Procedures Act.

A formal rejection of the CRC petition would enable the group to take the issue to the federal courts.  Gettman believes that, "The Obama Administration's refusal to act on this petition is an irresponsible stalling tactic; it denies us due process under the law and, more shamefully, it continues to deny countless patients a chance to use current law to seek legal access to marijuana for medical use."

The CSA classifies marijuana and other drugs in various schedules.  Marijuana is currently classified as a Schedule I substance, designating it as having a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. 

The CSA provides a procedure to have scheduling classifications changed in response to scientific research and other relevant factors, such as recognition of a drug's accepted medical use and its dependence liability as compared to other controlled substances.  Schedule I substances include heroin, GHB and MDMA (ecstasy).  Cocaine and oxycodone are both Schedule II substances, which allows for severely restricted medical use while maintaining the assertion that its abuse may lead to severe physiological and psychological dependence.  Marinol® a synthetic form of THC (marijuana) that is widely prescribed medically is a Schedule III substance designating that it has a currently accepted medical use in the United States and that's its abuse is associated with only a moderate dependence liability.

The members of the Coalition for Rescheduling Cannabis include the American Alliance for Medical Cannabis, Americans for Safe Access (ASA), California NORML, the Drug Policy Forum of Texas, High  Times, Los Angeles Cannabis Resource Center (Cooperative), the National Organization for the Reform of Marijuana Laws (NORML), New Mexicans for Compassionate Use, Oakland Cannabis Buyers Cooperative, and Patients Out of Time.

Further information:

Timeline of Efforts to Reschedule Marijuana

  • 1995 2001 – Prior attempt by Jon Gettman to reschedule cannabis ended with a rejection of the petition by then DEA head Asa Hutchinson
  • 2002 – Coalition for Rescheduling files new petition to DEA to reschedule marijuana.
  • 2003 – 2006 – HHS reviews all science relevant and makes recommendation to DEA
  • 2006 – Present – Coalition for Rescheduling Cannabis awaits final decision by DEA.

Writ filed: http://AmericansForSafeAccess.org/downloads/CRC_Writ.pdf

CRC rescheduling petition: http://www.drugscience.org/PDF/Petition_Final_2002.pdf

Additional Information: http://www.drugscience.org


'/>"/>
SOURCE DrugScience.org
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
2. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
3. State, Federal Officials Remind Health Care Workers, Other at-Risk Individuals to Get Annual Flu Shot
4. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
5. Mars, Incorporated Commits Over $2 Million to Federal Agency for Human-Animal Interaction Research
6. Southern Research to Play Key Role in the Federal Governments Search for New Cancer Therapies
7. Childrens Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections
8. Faced With Federal Prosecution, MountainView Agrees to Stop Harassment of RNs in Settlement With Labor Board
9. Malaria Experts Call on Federal Government to Increase Support for Research and Development
10. Federal Judge Rejects GlaxoSmithKlines Claims of Privilege
11. Chesley Files Federal Zicam Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
Breaking Medicine News(10 mins):